Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients
Obesity is a significant global public health concern that is associated with an elevated risk of comorbidities as well as severe postoperative and nosocomial infections. The treatment of infections in critically ill obese patients can be challenging because obesity affects the pharmacokinetics and...
Saved in:
Main Authors: | Julie Gorham (Author), Fabio S. Taccone (Author), Maya Hites (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Regimens of Novel Antibiotics in Critically Ill Patients with Varying Renal Functions: A Rapid Review
by: Julie Gorham, et al.
Published: (2022) -
How to Use Nebulized Antibiotics in Severe Respiratory Infections
by: Julie Gorham, et al.
Published: (2023) -
A Retrospective, Monocentric Study Comparing Co and Secondary Infections in Critically Ill COVID-19 and Influenza Patients
by: Diane Marcoux, et al.
Published: (2022) -
The Current Status and Future Perspectives of Beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients
by: Emmanuel Novy, et al.
Published: (2023) -
Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?
by: Daniela Baracaldo-Santamaría, et al.
Published: (2022)